
美国制药企业罕见病药品的市场开发策略
Market Development Strategies of Orphan Drugs Used by the USA Pharmaceutical Enterprises
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |